448 related articles for article (PubMed ID: 32493410)
1. Factors predictive of invasive ductal carcinoma in cases preoperatively diagnosed as ductal carcinoma in situ.
Takada K; Kashiwagi S; Asano Y; Goto W; Morisaki T; Takahashi K; Fujita H; Takashima T; Tomita S; Hirakawa K; Ohira M
BMC Cancer; 2020 Jun; 20(1):513. PubMed ID: 32493410
[TBL] [Abstract][Full Text] [Related]
2. The Effect of Smoking on Progression from Ductal Carcinoma
Takada K; Kashiwagi S; Asano Y; Goto W; Morisaki T; Shibutani M; Tanaka H; Hirakawa K; Ohira M
Anticancer Res; 2022 Jan; 42(1):311-320. PubMed ID: 34969739
[TBL] [Abstract][Full Text] [Related]
3. Sentinel lymph node biopsy is not necessary in patients diagnosed with ductal carcinoma in situ of the breast by stereotactic vacuum-assisted biopsy.
Kotani H; Yoshimura A; Adachi Y; Ishiguro J; Hisada T; Ichikawa M; Gondou N; Hattori M; Kondou N; Sawaki M; Fujita T; Iwata H
Breast Cancer; 2016 Mar; 23(2):190-4. PubMed ID: 24989112
[TBL] [Abstract][Full Text] [Related]
4. Predictors of invasive disease in patients preoperatively diagnosed with ductal carcinoma without stromal invasion, with breast magnetic resonance imaging (MRI) and ultrasound (US).
Maeda H; Hayashida T; Watanuki R; Kikuchi M; Nakashoji A; Yokoe T; Seki T; Takahashi M; Kitagawa Y
Breast Cancer; 2021 Mar; 28(2):398-404. PubMed ID: 33200381
[TBL] [Abstract][Full Text] [Related]
5. Preoperative clinicopathologic factors and breast magnetic resonance imaging features can predict ductal carcinoma in situ with invasive components.
Lee CW; Wu HK; Lai HW; Wu WP; Chen ST; Chen DR; Chen CJ; Kuo SJ
Eur J Radiol; 2016 Apr; 85(4):780-9. PubMed ID: 26971424
[TBL] [Abstract][Full Text] [Related]
6. Is it possible to predict underestimation in ductal carcinoma in situ of the breast? Yes, using a simple score!
Marques LC; Marta GN; de Andrade JZ; Andrade D; de Barros ACSD; Andrade FEM
Eur J Surg Oncol; 2019 Jul; 45(7):1152-1155. PubMed ID: 30665684
[TBL] [Abstract][Full Text] [Related]
7. Predictors of invasion in patients with core-needle biopsy-diagnosed ductal carcinoma in situ and recommendations for a selective approach to sentinel lymph node biopsy in ductal carcinoma in situ.
Huo L; Sneige N; Hunt KK; Albarracin CT; Lopez A; Resetkova E
Cancer; 2006 Oct; 107(8):1760-8. PubMed ID: 16977650
[TBL] [Abstract][Full Text] [Related]
8. Upstaging to invasive ductal carcinoma after mastectomy for ductal carcinoma in situ: predictive factors and role of sentinel lymph node biopsy.
Watanabe Y; Anan K; Saimura M; Koga K; Fujino M; Mine M; Tamiya S; Nishihara K; Nakano T; Mitsuyama S
Breast Cancer; 2018 Nov; 25(6):663-670. PubMed ID: 29786772
[TBL] [Abstract][Full Text] [Related]
9. Preoperatively diagnosed ductal cancers in situ of the breast presenting as even small masses are of high risk for the invasive cancer foci in postoperative specimen.
Szynglarewicz B; Kasprzak P; Halon A; Matkowski R
World J Surg Oncol; 2015 Jul; 13():218. PubMed ID: 26179898
[TBL] [Abstract][Full Text] [Related]
10. Factors associated with upstaging from ductal carcinoma in situ following core needle biopsy to invasive cancer in subsequent surgical excision.
Kim J; Han W; Lee JW; You JM; Shin HC; Ahn SK; Moon HG; Cho N; Moon WK; Park IA; Noh DY
Breast; 2012 Oct; 21(5):641-5. PubMed ID: 22749854
[TBL] [Abstract][Full Text] [Related]
11. Lack of definitive presurgical pathological diagnosis is associated with inadequate surgical margins in breast-conserving surgery.
Nasute Fauerbach PV; Tyryshkin K; Rodrigo SP; Rudan J; Fichtinger G; Reedijk M; Varma S; Berman DM
Eur J Surg Oncol; 2021 Oct; 47(10):2483-2491. PubMed ID: 34120811
[TBL] [Abstract][Full Text] [Related]
12. Axillary evaluation is not warranted in patients preoperatively diagnosed with ductal carcinoma in situ by core needle biopsy.
Si J; Guo R; Huang N; Xiu B; Zhang Q; Chi W; Wu J
Cancer Med; 2019 Dec; 8(18):7586-7593. PubMed ID: 31660702
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological predictors of postoperative upstaging to invasive ductal carcinoma (IDC) in patients preoperatively diagnosed with ductal carcinoma in situ (DCIS): a multi-institutional retrospective cohort study.
Tanaka K; Masuda N; Hayashi N; Sagara Y; Hara F; Kadoya T; Matsui A; Miyazaki C; Shien T; Tokunaga E; Hayashi T; Niikura N; Maeda S; Komoike Y; Bando H; Kanbayashi C; Iwata H
Breast Cancer; 2021 Jul; 28(4):896-903. PubMed ID: 33599914
[TBL] [Abstract][Full Text] [Related]
14. [Breast calcifications with percutaneous vacuum-assisted biopsy diagnosis of malignancy or atypical hyerplasia: correlations with surgical findings].
Piubello Q; Montemezzi S; D'Atri C
Pathologica; 2002 Dec; 94(6):299-305. PubMed ID: 12540993
[TBL] [Abstract][Full Text] [Related]
15. [Predictive factors of invasion with initial diagnosis of ductal carcinoma in situ based on core biopsy].
Kósa C; Garami Z; Dinya T; Fülöp B
Magy Seb; 2012 Aug; 65(4):218-21. PubMed ID: 22940391
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the underestimation rate in cases with ductal carcinoma in situ at ultrasound-guided core biopsy: 14-gauge automated core-needle biopsy vs 8- or 11-gauge vacuum-assisted biopsy.
Suh YJ; Kim MJ; Kim EK; Moon HJ; Kwak JY; Koo HR; Yoon JH
Br J Radiol; 2012 Aug; 85(1016):e349-56. PubMed ID: 22422382
[TBL] [Abstract][Full Text] [Related]
17. Prediction of underestimated invasiveness in patients with ductal carcinoma in situ of the breast on percutaneous biopsy as rationale for recommending concurrent sentinel lymph node biopsy.
Schulz S; Sinn P; Golatta M; Rauch G; Junkermann H; Schuetz F; Sohn C; Heil J
Breast; 2013 Aug; 22(4):537-42. PubMed ID: 23237921
[TBL] [Abstract][Full Text] [Related]
18. Predictive value of ductal carcinoma in situ with invasive breast cancer in core needle biopsies for final pathologic size of intraductal elements.
Matsumoto H; Ishii A; Nakada N; Koki A; Unesoko M; Abe N; Zaha H
Virchows Arch; 2022 Apr; 480(4):739-748. PubMed ID: 34993592
[TBL] [Abstract][Full Text] [Related]
19. Risk predictors of underestimation and the need for sentinel node biopsy in patients diagnosed with ductal carcinoma in situ by preoperative needle biopsy.
Park HS; Park S; Cho J; Park JM; Kim SI; Park BW
J Surg Oncol; 2013 Mar; 107(4):388-92. PubMed ID: 23007901
[TBL] [Abstract][Full Text] [Related]
20. Breast carcinoma in sclerosing adenosis: a clinicopathological and immunophenotypical analysis on 206 lesions.
Yu BH; Tang SX; Xu XL; Cheng YF; Bi R; Shui RH; Tu XY; Lu HF; Zhou XY; Yang WT
J Clin Pathol; 2018 Jun; 71(6):546-553. PubMed ID: 29436376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
